Fundraising FoxAscribe Bioscience
Ithaca, US · Founded 2021 · 5 known investors
Find your way into Ascribe Bioscience
Sign up to find every way you can get introduced to Ascribe Bioscience
- Your email: who you already know at Ascribe Bioscience, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ascribe Bioscience team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Ascribe Bioscience was founded in 2021 by Frank Schroeder.
Board
AB
KW
Investors · 5
Acre Venture Partnerslisted by Acre Venture PartnersSanta Monica · $100K – $10M
How we know: Acre Venture Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · businesswire.com · funding news · the VCSheet dataset · Not right? Tell us
Ponderosa Ventureslisted by Ponderosa VenturesSan Francisco · $100K – $750K
How we know: Ponderosa Ventures's portfolio page · Not right? Tell us
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Cortevalead
Reported raises · per SEC filings
Form D private placements$22.9M disclosed across 4 of 5 rounds · 2020–2025
▶$15MraisedOct 2025 · 11 investors · AgricultureRule 506(b)
▶$15MraisedOct 2025 · 11 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Alex BondarDirector
- Fred GruisDirector
- Frank SchroederDirector
- Jay FarmerExecutive Officer, Director
- Kyle WelbornDirector
- Offering amount
- $15.3M
- Amount sold
- $15M
- Minimum investment
- $5K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.1MraisedOct 2024 · 5 investors · AgricultureRule 506(b)
▶$2.1MraisedOct 2024 · 5 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- ALEX BONDARDirector
- FRANK SCHROEDERDirector
- JAY FARMERExecutive Officer, Director
- KYLE WELBORNDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $5K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.2MraisedAug 2022 · 7 investors · AgricultureRule 506(b)
▶$3.2MraisedAug 2022 · 7 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Jay FarmerExecutive Officer, Director
- Kyle WelbornDirector
- Alex BondarDirector
- Frank SchroederDirector
- Offering amount
- $3.3M
- Amount sold
- $3.2M
- Minimum investment
- $5K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MraisedSep 2021 · 12 investors · AgricultureRule 506(b)
▶$2.5MraisedSep 2021 · 12 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Kyle WelbornDirector
- Alex BondarDirector
- Jay FarmerExecutive Officer, Director
- Frank SchroederDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $5K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Ascribe Bioscience?
- Ascribe Bioscience was founded by Frank Schroeder in 2021.
- Who are Ascribe Bioscience's investors?
- Ascribe Bioscience's investors include Acre Venture Partners, Creative Destruction Lab (CDL), Ponderosa Ventures, Cultivation Capital.
- How much funding has Ascribe Bioscience raised?
- Ascribe Bioscience has disclosed $22.9M raised across 4 of its 5 known rounds.
- Where is Ascribe Bioscience headquartered?
- Ascribe Bioscience is headquartered in Ithaca, US.